: BioNTech shares soar 7% as COVID-19 vaccines help revenues smash estimates
Shares in BioNTech surged 7% on Monday, after the German biotech’s first-quarter earnings revealed a windfall of revenue and profit amid the global push to vaccinate against COVID-19.